133 related articles for article (PubMed ID: 25579428)
1. Inhibition of human efflux transporter ABCC2 (MRP2) by self-emulsifying drug delivery system: influences of concentration and combination of excipients.
Li L; Yi T; Lam CW
J Pharm Pharm Sci; 2014; 17(4):447-60. PubMed ID: 25579428
[TBL] [Abstract][Full Text] [Related]
2. Interactions between human multidrug resistance related protein (MRP2; ABCC2) and excipients commonly used in self-emulsifying drug delivery systems (SEDDS).
Li L; Yi T; Lam CW
Int J Pharm; 2013 Apr; 447(1-2):192-8. PubMed ID: 23462368
[TBL] [Abstract][Full Text] [Related]
3. A new mechanism for increasing the oral bioavailability of scutellarin with Cremophor EL: Activation of MRP3 with concurrent inhibition of MRP2 and BCRP.
Xiao L; Yi T; Chen M; Lam CW; Zhou H
Eur J Pharm Sci; 2016 Oct; 93():456-67. PubMed ID: 27586020
[TBL] [Abstract][Full Text] [Related]
4. Commonly used nonionic surfactants interact differently with the human efflux transporters ABCB1 (p-glycoprotein) and ABCC2 (MRP2).
Hanke U; May K; Rozehnal V; Nagel S; Siegmund W; Weitschies W
Eur J Pharm Biopharm; 2010 Oct; 76(2):260-8. PubMed ID: 20600890
[TBL] [Abstract][Full Text] [Related]
5. Modulation of Intestinal Transport and Absorption of Topotecan, a BCRP Substrate, by Various Pharmaceutical Excipients and Their Inhibitory Mechanisms of BCRP Transporter.
Sawangrat K; Yamashita S; Tanaka A; Morishita M; Kusamori K; Katsumi H; Sakane T; Yamamoto A
J Pharm Sci; 2019 Mar; 108(3):1315-1325. PubMed ID: 30389568
[TBL] [Abstract][Full Text] [Related]
6. Effects of spray-drying and choice of solid carriers on concentrations of Labrasol® and Transcutol® in solid self-microemulsifying drug delivery systems (SMEDDS).
Li L; Yi T; Lam CW
Molecules; 2013 Jan; 18(1):545-60. PubMed ID: 23282540
[TBL] [Abstract][Full Text] [Related]
7. Development and in vitro evaluation of a self-emulsifying drug delivery system (SEDDS) for oral vancomycin administration.
Zaichik S; Steinbring C; Caliskan C; Bernkop-Schnürch A
Int J Pharm; 2019 Jan; 554():125-133. PubMed ID: 30408530
[TBL] [Abstract][Full Text] [Related]
8. Effects of monoglycerides on rhodamine 123 accumulation, estradiol 17 beta-D-glucuronide bidirectional transport and MRP2 protein expression within Caco-2 cells.
Jia JX; Wasan KM
J Pharm Pharm Sci; 2008; 11(3):45-62. PubMed ID: 18801307
[TBL] [Abstract][Full Text] [Related]
9. Mrp2-related efflux of scutellarin in the intestinal absorption in rats.
Cao F; Zhang H; Guo J; Ping Q
Pharmazie; 2008 Jan; 63(1):75-80. PubMed ID: 18271309
[TBL] [Abstract][Full Text] [Related]
10. Self-emulsifying drug delivery systems and cationic surfactants: do they potentiate each other in cytotoxicity?
Lam HT; Le-Vinh B; Phan TNQ; Bernkop-Schnürch A
J Pharm Pharmacol; 2019 Feb; 71(2):156-166. PubMed ID: 30251762
[TBL] [Abstract][Full Text] [Related]
11. Multicomponent self nano emulsifying delivery systems of resveratrol with enhanced pharmacokinetics profile.
Vasconcelos T; Araújo F; Lopes C; Loureiro A; das Neves J; Marques S; Sarmento B
Eur J Pharm Sci; 2019 Sep; 137():105011. PubMed ID: 31330260
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity assessment of lipid-based self-emulsifying drug delivery system with Caco-2 cell model: Cremophor EL as the surfactant.
Bu P; Narayanan S; Dalrymple D; Cheng X; Serajuddin AT
Eur J Pharm Sci; 2016 Aug; 91():162-71. PubMed ID: 27328127
[TBL] [Abstract][Full Text] [Related]
13. Excipient effects on in vitro cytotoxicity of a novel paclitaxel self-emulsifying drug delivery system.
Gursoy N; Garrigue JS; Razafindratsita A; Lambert G; Benita S
J Pharm Sci; 2003 Dec; 92(12):2411-8. PubMed ID: 14603486
[TBL] [Abstract][Full Text] [Related]
14. MRP2-mediated transport of etoposide in MDCKII MRP2 cells is unaffected by commonly used non-ionic surfactants.
Nielsen S; Westerhoff AM; Gé LG; Carlsen KL; Pedersen MDL; Nielsen CU
Int J Pharm; 2019 Jun; 565():306-315. PubMed ID: 31085259
[TBL] [Abstract][Full Text] [Related]
15. Biopharmaceutical evaluation of surface active ophthalmic excipients using in vitro and ex vivo corneal models.
Juretić M; Cetina-Čižmek B; Filipović-Grčić J; Hafner A; Lovrić J; Pepić I
Eur J Pharm Sci; 2018 Jul; 120():133-141. PubMed ID: 29702232
[TBL] [Abstract][Full Text] [Related]
16. Formulation and in vivo assessment of terconazole-loaded polymeric mixed micelles enriched with Cremophor EL as dual functioning mediator for augmenting physical stability and skin delivery.
Abd-Elsalam WH; El-Zahaby SA; Al-Mahallawi AM
Drug Deliv; 2018 Nov; 25(1):484-492. PubMed ID: 29411650
[TBL] [Abstract][Full Text] [Related]
17. Sex-specific effects of excipients on oral drug bioavailability.
Mai Y; Madla CM; Shao H; Qin Y; Merchant HA; Murdan S; Basit AW
Int J Pharm; 2022 Dec; 629():122365. PubMed ID: 36336203
[TBL] [Abstract][Full Text] [Related]
18. Application of a mixture experimental design in the optimization of a self-emulsifying formulation with a high drug load.
Gao P; Witt MJ; Haskell RJ; Zamora KM; Shifflett JR
Pharm Dev Technol; 2004 Aug; 9(3):301-9. PubMed ID: 15458235
[TBL] [Abstract][Full Text] [Related]
19. The evaluation of some pharmaceutically acceptable excipients as permeation enhancers for amoxicillin.
Legen I; Kracun M; Salobir M; Kerc J
Int J Pharm; 2006 Feb; 308(1-2):84-9. PubMed ID: 16330171
[TBL] [Abstract][Full Text] [Related]
20. The effects of pluronics block copolymers and Cremophor EL on intestinal lipoprotein processing and the potential link with P-glycoprotein in Caco-2 cells.
Seeballuck F; Ashford MB; O'Driscoll CM
Pharm Res; 2003 Jul; 20(7):1085-92. PubMed ID: 12880295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
